Toward Better-Quality Compounded Drugs — An Update from the FDA

Since the 2012 fungal meningitis outbreak caused by a compounded drug that had been prepared under inappropriate conditions, the FDA’s experience in monitoring pharmacy compounding has demonstrated the need for further improvement in compounding practices.